NYU Langone Health, Laura & Isaac Perlmutter Cancer Center
NYU Langone Health, Laura & Isaac Perlmutter Cancer Center
New York, New York, United States1 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| ONC-392 Plus Lutetium Lu 177 Vipivotide Tetraxetan in Patients With mCRPC | Metastatic Castration-resistant Prostate Cancer | Active, not recruiting | Phase 1 / Phase 2 | 2026-05-22 | NCT05682443 |